12
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Cost-effectiveness of insulin degludec compared with insulin glargine in a basal-bolus regimen in patients with type 1 diabetes mellitus in the UK.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The aim of this study was to evaluate the cost-effectiveness of insulin degludec (IDeg) vs insulin glargine (IGlar) as part of a basal-bolus treatment regimen in adults with T1DM, using a short-term economic model.

          Related collections

          Author and article information

          Journal
          J Med Econ
          Journal of medical economics
          1941-837X
          1369-6998
          Jan 2015
          : 18
          : 1
          Affiliations
          [1 ] University Hospital Llandough , Cardiff , UK.
          Article
          10.3111/13696998.2014.971160
          25271378
          86674935-8885-4bf2-b270-5855eb14a32e
          History

          Cost-effectiveness,Insulin analogs,Insulin therapy,Nocturnal hypoglycemia,Pharmaco-economics,Type 1 diabetes

          Comments

          Comment on this article